July 24, 2016 5:42 PM ET

Pharmaceuticals

Company Overview of Euthymics Bioscience, Inc.

Executive Profile

Anthony A. McKinney MBA

Co-Founder, Chief Executive Officer, President and Director, Euthymics Bioscience, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
54--

Background

Mr. Anthony A. McKinney, MBA co-founded Euthymics Bioscience, Inc. in 2009 and serves as its Chief Executive Officer and President. Mr. McKinney served as the Chief Operating Officer of Orexigen Therapeutics, Inc. from January 2005 to December 5, 2008 and served as its Chief Business Officer. Mr. McKinney served as Senior Vice President of drug development and a founding member of Novazyme Pharmaceuticals, a company focusing on novel protein therapies for orphan diseases. ...

Corporate Headquarters

43 Thorndike Street
Cambridge, Massachusetts 02141

United States

Phone: 617-758-0300
Fax: 617-758-0420

Board Members Memberships

Co-Founder, Chief Executive Officer, President and Director

Education

BS
University of Oklahoma
MBA
Thunderbird School of Global Management

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Euthymics Bioscience, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.